1
Dorsey
Additional Material – Supplemental References
e1.Benito-Leon J, Bermejo-Pareja F, Rodriguez J, et al. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 2003;18:267-274.
e2.Kimura H, Kurimura M, Wada M, et al. Female preponderance of Parkinson’s disease in Japan. Neuroepidemiology 2002;21:292-296.
e3.Kis B, Schrag A, Ben-Shlomo Y, et al. Novel three-stage ascertainment method: prevalence of PD and parkinsonism in South Tyrol, Italy. Neurology 2002;58:1820-1825.
e4.Schrag A, Ben-Shlomo Y, Quinn NP. Cross sectional prevalence survey of idiopathic Parkinson’s disease and Parkinsonism in London. BMJ 2000;321:21-22.
e5.Errea JM, Ara JR, Aibar C, de Pedro-Cuesta J. Prevalence of Parkinson’s disease in lower Aragon, Spain. Mov Disord 1999;14:596-604.
e6.Kusumi M, Nakashima K, Harada H, Nakayama H, Takahashi K. Epidemiology of Parkinson’s disease in Yonago City, Japan: comparison with a study carried out 12 years ago. Neuroepidemiology 1996;15:201-207.
e7.Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidimiologic observations on Parkinson’s disease: incidence and mortality in a prospective study of middle-aged men. Neurology 1996;46:1044-1050.
e8.Wang SJ, Fuh JL, Teng EL, et al. A door-to-door survey of Parkinson’s disease in a Chinese population in Kinmen. Arch Neurol 1996;53:66-71.
e9.Mayeux R, Marder K, Cote LJ, et al. The frequency of idiopathic Parkinson’s disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.
e10.Morgante L, Rocca WA, Di Rosa AE, et al. Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. Neurology 1992;42:1901-1907.
e11.Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson’s disease in China. Chin Med J 1991;104:960-964.
e12.Okada K, Kobayashi S, Tsunematsu T. Prevalence of Parkinson’s disease in Izumo City, Japan. Gerontology 1990;36:340-344.
e13.Zhang ZX, Roman GC, Hong Z, et al. Parkinson’s disease in China: prevalence in Beijing, Xian, Shanghai. Lancet 2005;365:595-597.
e14.DasSK, Sanyal K. Neuroepidemiology of major neurological disorders in rural Bengal. Neurol India 1996;44:47-58.
e15.Razdan S, Kaul RL, Motta A, Kaul S, Bhatt RK. Prevalence and pattern of major neurological disorders in rural Kashmir (India) in 1986. Neuroepidemiology 1994;13:113-119.
e16.Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson’s disease in the Parsi community of Bombay, India. Arch Neurol 1988;45:1321-1323.
e17.Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson’s disease with and without dementia. Relationship to age and gender. Arch Neurol 1992;49:492-497.
e18.Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson’s disease in the biracial population of Copiah County, Mississippi. Neurology 1985;35:841-845.
e19.Tison F, Dartigues JF, Dubes L, Zuber M, Alperovitch A, Henry P. Prevalence of Parkinson’s disease in the elderly: a population study in Gironde, France. Acta Neurol Scand 1994; 90:111-115.
e20.Trankwalder C, Schwarz J, Gebhard J, et al. Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson’s disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 1995;52:1017-1022.
e21.Claveria LE, Duarte J, Sevillano MD, et al. Prevalence of Parkinson’s disease in Cantalejo, Spain: a door-to-door survey. Mov Disord 2002;17:242-249.
e22.Harada H, Nishikawa S, Takahashi K. Epidemiology of Parkinson’s disease in a Japanese city. Arch Neurol 1983;40:151-154.
e23.Bergareche A, De La Puente E, Lopez de Munain A, et al. Prevalence of Parkinson’s disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain. J Neurol 2004;251:340-345.
e24.Sutcliffe RL, Meara JR. Parkinson’s disease epidemiology in the Northampton District, England, 1992. Acta Neurol Scand 1995;92:443-450.
e25.Sutcliffe RL, Prior R, Mawby B, McQuillan WJ. Parkinson’s disease in the district of the Northampton Health Authority, United Kingdom. A study of prevalence and disability. Acta Neurol Scand 1985;72:363-379.
e26.Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK. Parkinson’s disease in a Scottish city. Br Med J (Clin Res Ed) 1986;292:534-536.
e27.Brewis M, PoskanzerDC, Rolland C, Miller H. Neurological disease in an English city. Acta Neurol Scand 1966;24:1-89.
e28.Singhal B, Lalkaka J, Sankhla C. Epidemiology and treatment of Parkinson’s disease in India. Parkinsonism Relat Disord 2003;9 Suppl 2:S105-S109.
e29.Martinez-SuarezNM, Blazquez-Menes B. Estimation of the prevalence of Parkinson’s disease in Asturia, Spain. A pharmacoepidemiological study of the consumption of antiparkinson drugs. Rev Neurol 2000;31:1001-1006.
e30.Criado-Alvarez JJ, Romo-Barrientos C, Martinez-Hernandez J, Gonzalez-Solana I. Use of antiparkinsonian agents in Castilla-La Mancha. Estimate of prevalence of Parkinson disease. Rev Neurol 1998;27:405-408.
e31.Artazcoz Sanz MT, Vines Rueda JJ. The estimation of prevalence of Parkinson disease in Navarra. An epidemiological study of the consumption of anti-parkinsonian drugs. Rev Esp Salud Publica 1995;69:479-485.
e32.Schoenberg BS, Osuntokum BO, Adeuja AO, et al. Comparison of the prevalence of Parkinson’s disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology 1988;38:645-646.
e33.von Campenhausen S, Bornschein B, Wick R, et al. Prevalence and incidence of Parkinson’s disease in Europe. Eur Neuropsychopharmacol 2005;15:473-490.
e34.de Rijk MC, Launer LJ, Berger K, et al. Prevalence of Parkinson’s disease in Europe: A collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000; 54 Suppl 5:S21-S23.
e35.Chouza C, Ketzoian C, Caamano JL, et al. Prevalence of Parkinson’s disease in a population of Uruguay. Preliminary results. Adv Neurol 1996;69:13-17.
e36.Nicoletti A, Sofia V, Bartoloni A, et al. Prevalence of Parkinson’s disease: a door-to-door survey in rural Bolivia. Parkinsonism Relat Disord 2003;10:19-21.
e37.Sanchez JL, Buritica O, Pineda D, Uribe CS, Palacio LG. Prevalence of Parkinson’s disease and parkinsonism in a Colombian population using the capture-recapture method. Int J Neurosci 2004;114:175-182.
e38.MelconMO, Anderson DW, Vergara RH, Rocca WA. Prevalence of Parkinson’s disease in Junin, Buenos Aires Province, Argentina. Mov Disord 1997;12:197-205.
e39.Taba P, Asser T. Prevalence of Parkinson’s disease in Estonia. Acta Neurol Scand 2002;106:276-281.
e40.Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-1022.
e41.IDB Population Pyramids. WashingtonDC: U.S. Census Bureau. Available at: Accessed December 5, 2005.